Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Temozolomide 23 Radiotherapy 10 Magnetic Resonance Spectroscopy 10 Radiation 8 Specimen Handling 7 Lomustine 4 Bevacizumab 4 Nivolumab 3 Biopsy 3 veliparib 2 trametinib 2 olaparib 2 lutetium Lu 177 dotatate 2 dabrafenib 2 cemiplimab 2 azeliragon 2 Surgical Procedures, Operative 2 Receptors, Interleukin-8B 2 Photons 2 Palliative Care 2 Ipilimumab 2 D2C7-(scdsFv)-PE38KDEL 2 CTLA-4 Antigen 2 Aminolevulinic Acid 2 vocimagene amiretrorepvec 1 varlilumab 1 ulixertinib 1 tinostamustine 1 temsirolimus 1 senicapoc 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × fluciclovine F-18 × 30 days × Clear all

NCT06319027 2026-05-15

GABLE

Eastern Cooperative Oncology Group

Phase 2 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡